Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novaferon in Advanced Neuroendocrine Tumors
NCT02455596Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of novaferon in neuroendocrine tumors (NETs), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
novaferon
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT02455596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455596.